Background: Adiponectin is an adipocyte-specific secretory protein that is highly
expressed in adipose tissue. Adiponectin levels are decreased in patients with metabolic
diseases, such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). NAFLD
has been associated with an increased risk of myocardial infarction (MI) in previous
studies.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
